Stay updated on Obeticholic Acid in NASH Clinical Trial
Sign up to get notified when there's something new on the Obeticholic Acid in NASH Clinical Trial page.

Latest updates to the Obeticholic Acid in NASH Clinical Trial page
- ChecktodayChange DetectedRevision: v3.3.4 added and Revision: v3.3.3 removed from the Study Documents section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedLocations section updated to include a comprehensive list of site locations by state and country, expanding the geographic reach of the trial. The HHS Vulnerability Disclosure entry and several location groupings were removed.SummaryDifference1%

- Check50 days agoChange DetectedThe Publications section now notes that items are automatically filled in from PubMed, and the page revision indicator shows Revision: v3.3.2.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded related topics 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics'; removed the government funding status notice.SummaryDifference0.1%

- Check64 days agoChange DetectedRemoved the related topics 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' from the page's related topics. This affects metadata and discoverability but leaves the study details, locations, and eligibility unchanged.SummaryDifference0.0%

- Check72 days agoChange DetectedNo significant changes detected in the page content. The study overview, eligibility criteria, outcomes, and location listings appear unchanged from the previous view.SummaryDifference0.1%

Stay in the know with updates to Obeticholic Acid in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeticholic Acid in NASH Clinical Trial page.